1-3 of 3
Sharmila C. Rai
Close
Sort by
Journal Articles

A phase 1 study of donor regulatory T-cell infusion plus low-dose interleukin-2 for steroid-refractory chronic graft-vs-host disease

Clinical Trials & Observations
Jennifer S. Whangbo, Sarah Nikiforow, Haesook T. Kim, Jonathan Wahl, Carol G. Reynolds, Sharmila C. Rai, Soomin Kim, Andrew Burden, Ana C. Alho, João F. Lacerda, Edwin P. Alyea, III, Corey S. Cutler, Vincent T. Ho, Joseph H. Antin, Robert J. Soiffer, Jerome Ritz, John Koreth
Journal: Blood Advances
Blood Adv (2022) 6 (21): 5786–5796.
https://doi.org/10.1182/bloodadvances.2021006625
Published: 2022
Includes: Supplemental data
Journal Articles

Allogeneic hematopoietic cell transplantation after prior targeted therapy for high-risk chronic lymphocytic leukemia

Haesook T. Kim, Conner J. Shaughnessy, Sharmila C. Rai, Carol Reynolds, Vincent T. Ho, Corey Cutler, John Koreth, Mahasweta Gooptu, Rizwan Romee, Sarah Nikiforow, Philippe Armand, Edwin P. Alyea, Joseph H. Antin, Catherine J. Wu, Robert J. Soiffer, Jerome Ritz, Jennifer R. Brown
Journal: Blood Advances
Blood Adv (2020) 4 (17): 4113–4123.
https://doi.org/10.1182/bloodadvances.2020002184
Published: 2020
Includes: Supplemental data
Journal Articles

Dose-escalated interleukin-2 therapy for refractory chronic graft-versus-host disease in adults and children

Clinical Trials & Observations
Jennifer S. Whangbo, Haesook T. Kim, Nikola Mirkovic, Lauren Leonard, Samuel Poryanda, Sophie Silverstein, Soomin Kim, Carol G. Reynolds, Sharmila C. Rai, Kelly Verrill, Michelle A. Lee, Steven Margossian, Christine Duncan, Leslie Lehmann, Jennifer Huang, Sarah Nikiforow, Edwin P. Alyea, III, Philippe Armand, Corey S. Cutler, Vincent T. Ho, Bruce R. Blazar, Joseph H. Antin, Robert J. Soiffer, Jerome Ritz, John Koreth
Journal: Blood Advances
Blood Adv (2019) 3 (17): 2550–2561.
https://doi.org/10.1182/bloodadvances.2019000631
Published: 2019
Includes: Supplemental data